Responsibility of assessment teams to review and biopsy abnormal axillary lymph nodes in women with malignant lesions at assessment

This clinical advice from the BreastScreen Australia (BSA) Clinical Advisory Committee (CAC) reviews whether axilla assessment should be done as part of their management.

Downloads

Responsibility of assessment teams to review and biopsy abnormal axillary lymph nodes in women with malignant lesions at assessment

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Publication date:
Last updated:
Publication type:
Guideline
Audience:
Health sector
Language:
English
Description:

The BSA CAC recommends that axilla assessment be formalised as part of a comprehensive management of women with grade 5 non-calcified lesions. Appropriate measurement parameters should be left to a Service’s clinical judgment.

Help us improve health.gov.au

If you would like a response please use the enquiries form instead.